Search for persons
X
?
1
Radial endobronchial ultrasound with a guide sheath for dia..:
Hayama, Manabu ; Okamoto, Norio ; Suzuki, Hidekazu...
http://www.biomedcentral.com/1471-2466/16/76. , 2016
http://www.biomedcentral.com/1471-2466/16/76. , 2016
?
2
Comparison of the clinical courses and chemotherapy outcome..:
Hirashima, Tomonori ; Nagai, Takayuki ; Shigeoka, Hironori...
http://www.biomedcentral.com/1471-2407/14/770. , 2014
http://www.biomedcentral.com/1471-2407/14/770. , 2014
?
3
Real-world outcomes of nivolumab plus ipilimumab and pembro..:
Matsumoto, Kinnosuke ; Shiroyama, Takayuki ; Tamiya, Motohiro...
Cancer Immunology, Immunotherapy. 2024, 73(4). ,
Cancer Immunology, Immunotherapy. 2024, 73(4). ,
?
4
Supplemental Table 1 from Phase II Study of the Liposomal F..:
Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103047. , 2024
https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103047. , 2024
?
7
Supplemental Table 4 from Phase II Study of the Liposomal F..:
Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038. , 2024
https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038. , 2024
?
10
Supplemental Figure 3 from Phase II Study of the Liposomal ..:
Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056. , 2024
https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056. , 2024
?
12
Presentation_1_Prognostic impact of clinical factors for im..:
Shota Takei ; Hayato Kawachi ; Tadaaki Yamada...
https://figshare.com/articles/presentation/Presentation_1_Prognostic_impact_of_clinical_factors_for_immune_checkpoint_inhibitor_with_or_without_chemotherapy_in_older_patients_with_non-small_cell_lung_cancer_and_PD-L1_TPS_50_pptx/25271359. , 2024
https://figshare.com/articles/presentation/Presentation_1_Prognostic_impact_of_clinical_factors_for_immune_checkpoint_inhibitor_with_or_without_chemotherapy_in_older_patients_with_non-small_cell_lung_cancer_and_PD-L1_TPS_50_pptx/25271359. , 2024
?
13
FIGURE 3 from Phase II Study of the Liposomal Formulation o..:
Makoto Nishio ; Shuji Murakami ; Hisato Kawakami...
https://figshare.com/articles/figure/FIGURE_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103068. , 2024
https://figshare.com/articles/figure/FIGURE_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103068. , 2024